Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep;39(9):1578-1591.
doi: 10.1002/mds.29881. Epub 2024 Jun 16.

Clinical and Molecular Profiling in GNAO1 Permits Phenotype-Genotype Correlation

Amaia Lasa-Aranzasti  1   2   3   4   5 , Yonika A Larasati  6 , Juliana da Silva Cardoso  2   7 , Gonzalo P Solis  6 , Alexey Koval  6 , Ana Cazurro-Gutiérrez  2   4 , Juan Dario Ortigoza-Escobar  8   9   10 , Maria Concepción Miranda  10   11   12 , Beatriz De la Casa-Fages  10   12   13 , Antonio Moreno-Galdó  14   15 , Eduardo F Tizzano  1   3   5 , David Gómez-Andrés  2   10   16 , Edgard Verdura  2 , Vladimir L Katanaev  6   17 , Belén Pérez-Dueñas  2   4   10   14   15 ; Study Group of GNAO1 patients from Spain
Collaborators, Affiliations

Clinical and Molecular Profiling in GNAO1 Permits Phenotype-Genotype Correlation

Amaia Lasa-Aranzasti et al. Mov Disord. 2024 Sep.

Abstract

Background: Defects in GNAO1, the gene encoding the major neuronal G-protein Gαo, are related to neurodevelopmental disorders, epilepsy, and movement disorders. Nevertheless, there is a poor understanding of how molecular mechanisms explain the different phenotypes.

Objectives: We aimed to analyze the clinical phenotype and the molecular characterization of GNAO1-related disorders.

Methods: Patients were recruited in collaboration with the Spanish GNAO1 Association. For patient phenotyping, direct clinical evaluation, analysis of homemade-videos, and an online questionnaire completed by families were analyzed. We studied Gαo cellular expression, the interactions of the partner proteins, and binding to guanosine triphosphate (GTP) and G-protein-coupled receptors (GPCRs).

Results: Eighteen patients with GNAO1 genetic defects had a complex neurodevelopmental disorder, epilepsy, central hypotonia, and movement disorders. Eleven patients showed neurological deterioration, recurrent hyperkinetic crisis with partial recovery, and secondary complications leading to death in three cases. Deep brain stimulation improved hyperkinetic crisis, but had inconsistent benefits in dystonia. The molecular defects caused by pathogenic Gαo were aberrant GTP binding and hydrolysis activities, an inability to interact with cellular binding partners, and reduced coupling to GPCRs. Decreased localization of Gαo in the plasma membrane was correlated with the phenotype of "developmental and epileptic encephalopathy 17." We observed a genotype-phenotype correlation, pathogenic variants in position 203 were related to developmental and epileptic encephalopathy, whereas those in position 209 were related to neurodevelopmental disorder with involuntary movements. Milder phenotypes were associated with other molecular defects such as del.16q12.2q21 and I344del.

Conclusion: We highlight the complexity of the motor phenotype, which is characterized by fluctuations throughout the day, and hyperkinetic crisis with a distinct post-hyperkinetic crisis state. We confirm a molecular-based genotype-phenotype correlation for specific variants. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Keywords: GNAO1 pathogenic variant; G‐protein; clinical phenotype; molecular etiology; movement disorders.

PubMed Disclaimer

References

    1. Nakamura K, Kodera H, Akita T, et al. De novo mutations in GNAO1, encoding a Gαo subunit of heterotrimeric G proteins, cause epileptic encephalopathy. Am J Hum Genet 2013;93(3):496–505.
    1. Menke LA, Engelen M, Alders M, Odekerken VJ, Baas F, Cobben JM. Recurrent GNAO1 mutations associated with developmental delay and a movement disorder. J Child Neurol 2016;31(14):1598–1601.
    1. Saitsu H, Fukai R, Ben‐Zeev B, et al. Phenotypic spectrum of GNAO1 variants: epileptic encephalopathy to involuntary movements with severe developmental delay. Eur J Hum Genet 2016;24(1):129–134.
    1. Feng H, Khalil S, Neubig RR, Sidiropoulos C. A mechanistic review on GNAO1‐associated movement disorder. Neurobiol Dis 2018;116:131–141.
    1. Krenn M, Sommer R, Sycha T, Zech M. GNAO1 Haploinsufficiency associated with a mild delayed‐onset dystonia phenotype. Mov Disord 2022;37(12):2464–2466.

Substances

LinkOut - more resources